Početna › Pločastostanični karcinom glave i vrata › Ohio
Kliničke studije za Pločastostanični karcinom glave i vrata u državi Ohio
46 studija za Pločastostanični karcinom glave i vrata traži sudionike na lokacijama u državi Ohio.
Gradovi u državi Ohio
- Columbus20 studija
- Cleveland18 studija
- Cincinnati14 studija
- Toledo8 studija
- Akron5 studija
- Youngstown5 studija
- Dayton5 studija
Službeni tekst studije (engleski)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Aultman Health Foundation, Canton
- Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06992427FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Site#0154, Canton
- Site#0117, Cincinnati
- Site #0151, Cleveland
- i još 1
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06788990A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University Hospitals Cleveland Medical Center, Cleveland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06465069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #10, Cleveland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT05176483Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Miami Valley Hospital South, Centerville
- Miami Valley Hospital, Dayton
- Miami Valley Hospital North, Dayton
- i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06589804A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 10, Columbus
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07085091A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Site 06, Maumee
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07814248BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Miami Valley Hospital South, Centerville
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- i još 2
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05136196A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- University of Cincinnati, Cincinnati
- Ohio State University, Columbus
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07276399JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
- University of Cincinnati, Cincinnati
U tijeku regrutacijaFaza 3
Od 60 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT04892173Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06980038A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Cleveland Clinic, Cleveland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06385080Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Miami Valley Hospital South, Centerville
- Cleveland Clinic Foundation, Cleveland
- Premier Blood and Cancer Center, Dayton
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 79 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT04671667A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- UH Cleveland Medical Center, Cleveland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. ruj 2026. · NCT07109726Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- UH Seidman Cancer Center at UH Avon Health Center, Avon
- Indu and Raj Soin Medical Center, Beavercreek
- Saint Elizabeth Boardman Hospital, Boardman
- i još 22
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT02734537ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cleveland Clinic, Cleveland
- Toledo Clinic Cancer Center, Toledo
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT05059444Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Research Site, Columbus
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT06535607First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. ruj 2026. · NCT06657222A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- University of Cincinnati, Cincinnati
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06163534A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Ohio State University, Columbus
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 21. kol 2026. · NCT06769698A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Maumee
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07182149Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Cleveland Clinic Foundation, Cleveland
- Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Summa Health System - Akron Campus, Akron
- Aultman Health Foundation, Canton
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- i još 2
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- ProMedica Flower Hospital, Sylvania
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo
- i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT07441681Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- The Ohio State University, Columbus
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. kol 2026. · NCT05985655SMP-3124LP in Adults With Advanced Solid Tumors
- Ohio State University, Columbus
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 12. kol 2026. · NCT06526819Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation, Cleveland
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT06627270A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- Cleveland Clinic, Cleveland
- Ohio State University, Columbus
- Taylor Cancer Research Center, Maumee
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 29. srp 2026. · NCT03526835Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 24. srp 2026. · NCT04754321A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- University Hospitals Cleveland Medical Center, Cleveland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT05208762First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- UH Cleveland Medical Center, Cleveland
- Stefanie Spielman Comprehensive Breast Center, Columbus
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT05768139Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
- University of Cincinnati Medical Center, Cincinnati
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 1. srp 2026. · NCT07213934A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Canton
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 26. svi 2026. · NCT06256588Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
- University of Cincinnati Medical Center, Cincinnati
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 18. svi 2026. · NCT07497607A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers
- The Cleveland Clinic Foundation, Cleveland
U tijeku regrutacijaFaza 2/3
Od 18 do 100 godina · Oba spola · Ažurirano 23. tra 2026. · NCT05893888A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. tra 2026. · NCT06064877A Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 6. tra 2026. · NCT05785741Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
- Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 24. ožu 2026. · NCT06323460Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Cleveland Clinic, Cleveland
- Taylor Cancer Research Center, Maumee
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 18. velj 2026. · NCT07030257Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- Ohio State University Medical Center, Columbus
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. velj 2026. · NCT01473784Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.